Autonomous innovation is enabling consumer goods companies to stay ahead of trends – and their competitors.
Market movements, social trends and scientific breakthroughs are turned into new product concepts, predicting a consumer need before it arises. The concepts are tested and refined for viability, feasibility and desirability, in synthetic environments before building and launching them. New products are launched, marketed and sold autonomously, and product concepts are refined based on real-world learnings.
AI-powered, autonomous innovation allows the discovery, exploration and testing of new services and concepts in otherwise hard-to-validate environments within B2B and industrials. For example, we’ve have partnered with a global leader in construction to uncover 200+ new concepts and opportunities in three days, rooted in market trends and powered by AI. These concepts were validated synthetically against 5 different buyer personas – which we built using our synthetic GenAI framework. The data was based on 40+ interviews with these personas in different markets.
From improving medical diagnosis and transforming patient experiences to speeding up drug discovery, autonomous innovation has a transformational role to play in healthcare. Autonomous Innovation is enabling the discovery of new drugs by autonomously ideating and testing potential new molecules for existing conditions.
197 Grand Street, Ste 5W, New York, NY 10013